-
Company Insights
![]()
F. Hoffmann-La Roche Ltd – Digital Transformation Strategies
Roche Digital Transformation Strategies Report Overview Hoffmann La Roche Ltd (Roche) has been focusing on using cloud, artificial intelligence, and data science to digitally transform its operations. The annual ICT spending of Roche was estimated at $3.1 billion for 2023. A major share of this spending is earmarked for acquiring network and communications, ICT services, and hardware from vendors. Roche is a healthcare company that develops drugs and diagnostics devices for treating diseases. It provides medicines and diagnostics for oncology,...
-
Company Profile
New![]()
PathAI Inc – Company Profile
PathAI Inc is a provider of AI-powered technology for the pathology laboratory services. The company specializes in delivering the transformative tools for pathologists that can help accelerate drug development in therapeutic areas such as oncology; breast cancer, lung cancer, non-alcoholic steatohepatitis (NASH), and inflammatory bowel diseases, and among others. Its biopharma service offerings include translational research, clinical development, diagnostic development and commercialization, real-world data services, clinical and commercial lab services. The company uses AISight precision-pathology platform, AI-powered algorithms, artificial intelligence,...
Add to Basket -
Analyst Opinions
![]()
New Prescription – Generative Artificial Intelligence (AI) Meets Healthcare
Generative Artificial Intelligence (AI) in Healthcare Report Overview Generative AI can accelerate pharmaceutical drug discovery, enhance clinical trials and drug approval, optimize manufacturing and the supply chain, boost sales and marketing, and improve healthcare delivery as well as patient outcomes. For instance, pharmaceutical drug discovery can be enhanced by automating target identification and optimizing lead generation, significantly reducing the time and resources required in drug development. Furthermore, Generative AI enhances clinical trials by facilitating the eligibility screening process, enrollment, predicting outcomes,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.